Related references
Note: Only part of the references are listed.Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence
Fred Poordad et al.
HEPATOLOGY (2016)
New perspectives for preventing hepatitis C virus liver graft infection
Daniel J. Felmlee et al.
LANCET INFECTIOUS DISEASES (2016)
OPTN/SRTR 2013 Annual Data Report: liver
W. R. Kim et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Sofosbuvir Treatment in the Pre and Post Liver Transplantation Phase: The Sooner, the Better
Alessio Aghemo et al.
GASTROENTEROLOGY (2015)
Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study
Michael P. Curry et al.
GASTROENTEROLOGY (2015)
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
Michael Charlton et al.
GASTROENTEROLOGY (2015)
Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis
Bashar A. Aqel et al.
HEPATOLOGY (2015)
Fine Mapping of Murine Antibody Responses to Immunization with a Novel Soluble Form of Hepatitis C Virus Envelope Glycoprotein Complex
Tinashe B. Ruwona et al.
JOURNAL OF VIROLOGY (2014)
An Interferon-free Antiviral Regimen for HCV after Liver Transplantation
Paul Y. Kwo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Human Monoclonal Antibody MBL-HCV1 Delays HCV Viral Rebound Following Liver Transplantation: A Randomized Controlled Study
R. T. Chung et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Glycan Shifting on Hepatitis C Virus (HCV) E2 Glycoprotein Is a Mechanism for Escape from Broadly Neutralizing Antibodies
Homer Pantua et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Viral Hepatitis in Liver Transplantation
Gonzalo Crespo et al.
GASTROENTEROLOGY (2012)
Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy
Ilaria Vicenti et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees
Trevor J. Morin et al.
PLOS PATHOGENS (2012)
Impact of Virologic Breakthrough and HBIG Regimen on Hepatitis B Recurrence After Liver Transplantation
B. Degertekin et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Post-Liver Transplant Cholestatic Hepatitis C: A Systematic Review of Clinical and Pathological Findings and Application of Consensus Criteria
Torun K. Narang et al.
LIVER TRANSPLANTATION (2010)
Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus
Teresa J. Broering et al.
JOURNAL OF VIROLOGY (2009)
Natural History of Post-Liver Transplantation Hepatitis C: A Review of Factors That May Influence Its Course
Juan F. Gallegos-Orozco et al.
LIVER TRANSPLANTATION (2009)
Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3•4A protease inhibitors in treatment-naive subjects
Doug J. Bartels et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients
Tara L. Kieffer et al.
HEPATOLOGY (2007)
Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation
A Blasco et al.
HEPATOLOGY (2006)
Kinetics of hepatitis C virus reinfection after liver transplantation
KA Powers et al.
LIVER TRANSPLANTATION (2006)
New era of liver transplantation for hepatitis B - A 17-year single-center experience
DM Anselmo et al.
ANNALS OF SURGERY (2002)
Share Paper
